In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $0.63 in the prior trading day, Leap Therapeutics Inc (NASDAQ: LPTX) closed at $0.75, up 19.75%. In other words, the price has increased by $19.75 from its previous closing price. On the day, 4.24 million shares were traded. LPTX stock price reached its highest trading level at $0.7664 during the session, while it also had its lowest trading level at $0.62.
Ratios:
Our goal is to gain a better understanding of LPTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.34 and its Current Ratio is at 1.34. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on January 29, 2025, Downgraded its rating to Neutral and sets its target price to $1.25 from $9 previously.
On June 28, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $8.Rodman & Renshaw initiated its Buy rating on June 28, 2024, with a $8 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LPTX now has a Market Capitalization of 31083790 and an Enterprise Value of 12992791.
Stock Price History:
The Beta on a monthly basis for LPTX is -0.09, which has changed by -0.67811155 over the last 52 weeks, in comparison to a change of 0.16845357 over the same period for the S&P500. Over the past 52 weeks, LPTX has reached a high of $4.79, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is 114.91%, while the 200-Day Moving Average is calculated to be 10.36%.
Shares Statistics:
The stock has traded on average 3.15M shares per day over the past 3-months and 14636730 shares per day over the last 10 days, according to various share statistics. A total of 41.44M shares are outstanding, with a floating share count of 33.39M. Insiders hold about 19.43% of the company’s shares, while institutions hold 20.37% stake in the company. Shares short for LPTX as of 1757894400 were 1417952 with a Short Ratio of 0.45, compared to 1755216000 on 1733805. Therefore, it implies a Short% of Shares Outstanding of 1417952 and a Short% of Float of 4.02.
Earnings Estimates
A detailed examination of Leap Therapeutics Inc (LPTX) is currently in progress, with 1.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.2 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$1.11 and -$1.11 for the fiscal current year, implying an average EPS of -$1.11. EPS for the following year is -$0.53, with 1.0 analysts recommending between -$0.53 and -$0.53.
